Apollomics, Inc.

NASDAQ:APLM

Biotechnology

Healthcare
$17.84 +34.72%

+$6.03 today

Market cap
$52.00M
Beta
1.45
P/E (TTM)
-3.1
EPS (TTM)
-$25.98
52W Low $3.66High $42.12

Volume 0.02M

Average 0.02M

APLM EPS (Diluted)

Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.

Apollomics, Inc.NASDAQ: APLM

EPS (Diluted) · Q4 FY2025 · quarter ended Dec 2025

EPS (Diluted) turns positive

Q4 FY2025 EPS (Diluted) was $3.8, compared with -$16.92 a year earlier.

Context

  • EPS (Diluted) grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Diluted) reaches the consensus estimate from 1 analysts of -$122 (-1511.6%) for the fiscal year ending Dec 2026, a slowdown from the +85.7% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
$3.8— QoQ
Last fiscal yearDec 2025
-$7.57+85.7% YoY
EPS (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+122.5%——
1 year+85.7%-1511.6%-1597.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Diluted) history

USD · from the income statement

Latest · FY2025
(7.57) USD
Year-over-year change
+85.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Diluted) vs competitors

How APLM compares with its peers on the latest reported figures

  • APLM's FY2025 EPS (Diluted) of -$7.57 is the lowest of the 2 companies compared; the peer median is -$7.08.
APLM Competitors Peer median
EPS (Diluted) for APLM and competitors
Company Period LTM YoY 3-year CAGR
ANLAdlai Nortye Ltd.LTM Jun 2024-$7.08 ——
APLMApollomics, Inc.FY2025-$7.57 +85.7%—
Peer median (excluding APLM) -$7.08——

Competitors are the stored peer set for APLM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2K323K821K198K8.5M
Cost of Revenue0000255K
Gross Profit2K323K821K198K8.25M
Gross Margin100.0%100.0%100.0%100.0%97.0%
Research & Development35.57M35.46M34.19M24.57M5.53M
Selling, General & Admin15.29M9.95M20.64M17.77M12.44M
Operating Expenses50.86M45.4M54.83M42.33M17.72M
Depreciation & Amortization153K182K103K72K255K
EBITDA(50.12M)(43.88M)(53.45M)(41.06M)(9.22M)
EBITDA Margin-2505850.0%-13586.1%-6509.9%-20734.8%-108.4%
Operating Income(50.86M)(45.08M)(54.01M)(42.14M)(9.47M)
Operating Margin-2542850.0%-13957.0%-6578.9%-21280.8%-111.4%
Interest Income467K431K753K480K152K
Interest Expense83K93K150K179K65K
Other Income / Expenses(43.94M)(195.73M)(118.58M)(11.46M)(1.46M)
Income Before Tax(94.8M)(240.81M)(172.59M)(53.6M)(10.94M)
Pre-Tax Margin-4739800.0%-74554.2%-21022.0%-27070.2%-128.7%
Income Tax Expense1K1K10K259K3K
Net Income(94.8M)(240.81M)(172.6M)(53.86M)(10.94M)
Net Margin-4739850.0%-74554.5%-21023.3%-27201.0%-128.7%
EPS (Basic)(23.45)(61.60)(231.99)(52.80)(7.57)
EPS (Diluted)(23.45)(61.60)(231.99)(52.80)(7.57)
Weighted Avg Shares867.96K867.96K743.97K926.47K1.45M
Weighted Avg Shares (Diluted)867.96K867.96K743.97K926.47K1.45M

Apollomics, Inc.

NASDAQ:APLM

Intrinsic Alpha fair value

Locked

Current Price

$17.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.